Klotho Neurosciences (KLTO) Competitors $0.17 +0.00 (+1.67%) As of 03:56 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsOwnershipSEC FilingsTrendsBuy This Stock KLTO vs. GRCE, LSB, JATT, RLYB, ANVS, SNYR, CDIO, CVM, LSTA, and NNVCShould you be buying Klotho Neurosciences stock or one of its competitors? The main competitors of Klotho Neurosciences include Grace Therapeutics (GRCE), Lakeshore Biopharma (LSB), JATT Acquisition (JATT), Rallybio (RLYB), Annovis Bio (ANVS), Synergy CHC Corp. (Uplisting) (SNYR), Cardio Diagnostics (CDIO), CEL-SCI (CVM), Lisata Therapeutics (LSTA), and NanoViricides (NNVC). These companies are all part of the "pharmaceutical products" industry. Klotho Neurosciences vs. Grace Therapeutics Lakeshore Biopharma JATT Acquisition Rallybio Annovis Bio Synergy CHC Corp. (Uplisting) Cardio Diagnostics CEL-SCI Lisata Therapeutics NanoViricides Klotho Neurosciences (NASDAQ:KLTO) and Grace Therapeutics (NASDAQ:GRCE) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, community ranking, media sentiment, analyst recommendations and dividends. Do analysts prefer KLTO or GRCE? Grace Therapeutics has a consensus target price of $12.00, suggesting a potential upside of 468.72%. Given Grace Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Grace Therapeutics is more favorable than Klotho Neurosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Klotho Neurosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Grace Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, KLTO or GRCE? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKlotho NeurosciencesN/AN/A$1.35MN/AN/AGrace TherapeuticsN/AN/A-$12.85M-$1.16-1.82 Does the MarketBeat Community prefer KLTO or GRCE? Grace Therapeutics received 1 more outperform votes than Klotho Neurosciences when rated by MarketBeat users. CompanyUnderperformOutperformKlotho NeurosciencesN/AN/AGrace TherapeuticsOutperform Votes1100.00% Underperform VotesNo Votes Do insiders and institutionals hold more shares of KLTO or GRCE? 20.1% of Klotho Neurosciences shares are held by institutional investors. Comparatively, 6.1% of Grace Therapeutics shares are held by institutional investors. 2.0% of Klotho Neurosciences shares are held by company insiders. Comparatively, 13.5% of Grace Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is KLTO or GRCE more profitable? Klotho Neurosciences' return on equity of 0.00% beat Grace Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Klotho NeurosciencesN/A N/A -25.89% Grace Therapeutics N/A -20.10%-17.10% Does the media favor KLTO or GRCE? In the previous week, Klotho Neurosciences' average media sentiment score of 1.89 beat Grace Therapeutics' score of 0.63 indicating that Klotho Neurosciences is being referred to more favorably in the media. Company Overall Sentiment Klotho Neurosciences Very Positive Grace Therapeutics Positive SummaryGrace Therapeutics beats Klotho Neurosciences on 6 of the 10 factors compared between the two stocks. Remove Ads Get Klotho Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLTO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLTO vs. The Competition Export to ExcelMetricKlotho NeurosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.64M$2.82B$5.27B$7.32BDividend YieldN/A1.87%5.11%4.31%P/E RatioN/A30.3921.6617.68Price / SalesN/A431.61377.2292.80Price / Cash0.95168.6838.1534.64Price / Book-0.083.386.363.94Net Income$1.35M-$72.06M$3.20B$247.45M7 Day PerformanceN/A4.36%4.07%3.32%1 Month Performance-42.46%-18.93%-10.26%-8.51%1 Year PerformanceN/A-29.05%10.36%0.66% Klotho Neurosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLTOKlotho NeurosciencesN/A$0.17+1.7%N/AN/A$4.76MN/A0.00N/AGap DownGRCEGrace Therapeutics1.9494 of 5 stars$1.80-10.0%$12.00+566.7%N/A$18.25MN/A-1.55N/AGap DownLSBLakeshore Biopharma0.6733 of 5 stars$1.95-6.7%N/AN/A$18.15M$672.27M0.00773Upcoming EarningsShort Interest ↑News CoverageGap UpHigh Trading VolumeJATTJATT AcquisitionN/A$1.03-5.1%N/A-63.7%$17.77MN/A0.003High Trading VolumeRLYBRallybio2.421 of 5 stars$0.42-5.6%$9.75+2,194.7%-86.0%$17.68M$636,000.00-0.2740Analyst ForecastGap DownANVSAnnovis Bio1.453 of 5 stars$1.24-5.7%$37.00+2,896.0%-87.5%$17.58MN/A-0.283Gap UpSNYRSynergy CHC Corp. (Uplisting)3.1198 of 5 stars$2.03-11.7%$10.00+392.6%N/A$17.40M$34.83M0.0040Lockup ExpirationNews CoverageGap DownHigh Trading VolumeCDIOCardio Diagnostics2.1301 of 5 stars$0.33+7.1%$2.00+511.2%-63.7%$17.06M$34,890.000.001Short Interest ↑CVMCEL-SCIN/A$0.21-3.5%N/A-83.1%$16.71MN/A-0.4343Analyst ForecastGap UpLSTALisata Therapeutics2.2615 of 5 stars$1.90-4.5%$15.00+689.5%-27.5%$16.38M$1M-0.7630News CoveragePositive NewsNNVCNanoViricidesN/A$1.04-3.7%N/A+18.6%$16.27MN/A-1.4420Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies Grace Therapeutics Competitors Lakeshore Biopharma Competitors JATT Acquisition Competitors Rallybio Competitors Annovis Bio Competitors Synergy CHC Corp. (Uplisting) Competitors Cardio Diagnostics Competitors CEL-SCI Competitors Lisata Therapeutics Competitors NanoViricides Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KLTO) was last updated on 4/17/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Klotho Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Klotho Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KLTO Stock Free KLTO Stock Alerts